Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Gets Price Target Boost from Citigroup

Summary by MarketBeat
Citigroup boosted their price target on Regeneron Pharmaceuticals from $740.00 to $825.00 and gave the company a "neutral" rating in a research note on Friday.

1 Articles

MarketBeatMarketBeat
Center

Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Gets Price Target Boost from Citigroup

Citigroup boosted their price target on Regeneron Pharmaceuticals from $740.00 to $825.00 and gave the company a "neutral" rating in a research note on Friday.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Friday, October 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Citigroup icon

Citigroup

Tarrytown icon

Tarrytown

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal